Compound class:
Synthetic organic
Comment: GSK8814 is a chemical probe for the ATAD2/2B bromodomain [1] and is available via the Stuctural Genomics Consortium's chemical probe dissemination program. Click here to link to the SGC's full list of epigenetics probes.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
The potency of GSK8814 vs. the BET bromodomains of BRD2, -3 and -4 and BRDT approached the lower limit of assay detection, resulting in a selectivity of >2.8 logs in favour of the ATAD2 bromodomain [1]. In a BROMOscan panel GSK8814 inhibited only ATAD2B (with similar potency to ATAD2), TAF1 BD2 (>2 logs selectivity) and TAF1L BD2 (2.5 logs selectivity) in addition to its intended target. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|